News

Filter
271 found

MMV delivers statement at 140th session of the WHO Executive Board

27 Jan 2017

MMV welcomes the launch of the End Malaria Council

25 Jan 2017

MMV brings new partner Janssen Pharmaceuticals on board

19 Jan 2017

MMV end-of-year review 2016

22 Dec 2016

Swiss Malaria Group invites you to enter photo and video competition

17 Dec 2016

Cipla’s artesunate suppository first to be quality-assured by Global Fund

16 Dec 2016

World Malaria Report 2016 reveals improved malaria control for vulnerable but substantial gaps remain

13 Dec 2016

MMV partner GSK ranked first in the Access to Medicine Index – again

17 Nov 2016

MMV partner Prof. David Fidock wins the 2016 Advance Global Australian of the Year Award in Life Sciences

21 Oct 2016

First open source malaria publication describes new way to do drug discovery

14 Sep 2016

PLOS Pathogens publishes the Malaria Box findings

28 Jul 2016

MMV awards seven endemic-region scientists Challenge Grants to ‘exploit the Pathogen Box’

25 Jul 2016

Malaria community mourns the tragic loss of Dr Sylvia Meek

23 May 2016

Endemic-Region Challenge Grants of USD 50,000 each available to exploit the Pathogen Box

31 Mar 2016

MMV welcomes WHO approval of 3-year shelf-life for antimalarial ASMQ

08 Mar 2016

Mr Yong Taek Chang, Chairman of Shin Poong Pharmaceutical passes away

07 Mar 2016

MMV delivers statement at WHO Executive Board meeting

29 Jan 2016

MMV welcomes George Osborne and Bill Gates’ £3 billion pledge for malaria

27 Jan 2016

MMV launches the Pathogen Box

14 Dec 2015

WHO reports a ‘dramatic decline’ in malaria burden since 2000

09 Dec 2015

Delivery of Coartem® Dispersible reaches a landmark of 300 million treatments

09 Dec 2015

Ray Chambers entrusts Chairmanship of MMV to Per Wold-Olsen

04 Dec 2015
European regulators grant Pyramax® a revised label

European regulators grant Pyramax® a revised label

20 Nov 2015
Social media award winners

2015 Social media malaria heroes announced

17 Nov 2015

Eurartesim® (dihydroartemisinin-piperaquine) receives WHO prequalification

26 Oct 2015

Comic books, science fiction and colour inspire two of ‘175 Faces of Chemistry’

09 Oct 2015

Nobel in Medicine awarded to parasitic disease drug pioneers

05 Oct 2015

Leader in the fight against malaria passes away

21 Sep 2015

WHO awards over $1 million to MMV’s ‘Exploiting the Pathogen Box’ project

19 Aug 2015

Call to nominate forward-thinking malaria heroes

13 Aug 2015

MMV welcomes launch of WHO P. vivax technical brief

29 Jul 2015

Pre-clinical assessment of exciting new malaria drug candidate published

16 Jul 2015

OZ439 recognized as a high-impact innovation to transform global health

16 Jul 2015

MMV wins Tim Berners-Lee’s Open Data Innovation Award

10 Jul 2015
Dr David Reddy, CEO, MMV and Dr Bernard Pécoul, CEO, DNDi

DNDi passes the ball to MMV

22 May 2015

MMV delivers statement at 68th World Health Assembly

19 May 2015

MMV joins the Asia Pacific Malaria Elimination Network (APMEN)

23 Apr 2015

MMV recognizes outstanding achievements of ISMO partners

09 Apr 2015

MMV welcomes continued Australian government support

24 Mar 2015

MMV awards challenge grants to seven Malaria Box recipients

06 Mar 2015

First Chair of MMV’s ESAC receives knighthood

12 Jan 2015

WHO’s much-awaited World Malaria Report reveals progress in the fight against malaria

10 Dec 2014

Three new roads leading to a common pathway

09 Dec 2014

Call for stories and ideas for GMAP2

20 Nov 2014

Child-friendly antimalarial reaches new landmark of 250 million treatments delivered

19 Nov 2014

MMV partner Prof. Luiz Carlos Dias receives Santander University Award

13 Nov 2014

300,000 vials of injectable artesunate delivered to Kenya and Nigeria

04 Nov 2014

Guilin’s SP+AQ added to WHO’s “List of Prequalified Products”

29 Oct 2014

Pyramax now registered in Cambodia

15 Oct 2014

NIH scientist Dr Martin John Rogers has passed away

09 Sep 2014

MMV organizes international malaria conference in Berlin

01 Jul 2014

MMV launches the Seasonal Malaria Chemoprevention Tool Kit

29 Apr 2014

MMV and Merck Serono join forces in antimalarial drug discovery

24 Feb 2014

MMV and partners call for compounds to fill the Pathogen Box

18 Feb 2014
© iStock.com/combojan fatur

Takeda collaborates with MMV through GHIT Fund

24 Dec 2013

Tafenoquine successfully completes Phase IIb clinical trials

19 Dec 2013

State-of-the-art laboratory to study new antimalarials opens in Jakarta

10 Dec 2013

Rise in R&D funding could set the stage for malaria eradication

10 Dec 2013

New antimalarial drug target identified

29 Nov 2013

Partners commit to bolstering open source research

27 Nov 2013

Pages